The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations
BJ Dunmore(University of Cambridge), Nicholas W. Morrell(University of Cambridge)
Cited by 100
Related Papers
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
|Nature Medicine|2015|503
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
|Nature Communications|2018|380
Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension
|Circulation|2009|258
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling
|Nature Communications|2017|229